Computerized/Automated Endoscope Reprocessors offer a few focal points over manual reprocessing. They mechanize and institutionalize a few essential reprocessing steps, in this manner taking out the likelihood of missed strides in light of human blunder, and minimize exposure of endoscopy or sterile processing division staff to HLDs (high level of disinfection) or compound sterilants.
The global automated endoscope reprocessors market is estimated to account for US$ 424.8 Mn in terms of value and is expected to reach US$ 706.3 Mn by the end of 2027.
Global Automated Endoscope Reprocessors Market: Drivers
Increasing concern about patient safety is expected to propel growth of the global automated endoscope reprocessors market over the forecast period. Rising awareness regarding use of automated endoscope reprocessors for securement of exogenous and endogenous infections associated with flexible endoscopy in developing countries is expected to fuel demand. Moreover, FDA, SGNA (Society for Gastroenterology Nurses and Associates, Inc.), CDC and ASGE (American Society for Gastrointestinal Endoscopy) examiners bolster expanded research in the regions of endoscope plan and urge makers to create adaptable gastrointestinal endoscopes that can be effortlessly dismantled for reprocessing and confirmation of cleaning and abnormal state sterilization and have institutionalized conventions for further reprocessing.
Global Automated Endoscope Reprocessors Market: Opportunities
Increasing prevalence of gastrointestinal disorders is expected to offer lucrative growth opportunities for players in the global automated endoscope reprocessors market. For instance, according to the study, ‘A study of prevalence and determinants of irritable bowel syndrome in an urban slum community in Mumbai’, published in November 2018, the prevalence of irritable bowel syndrome was 12.27%, of which 56% were males and 44% were females.
Global Automated Endoscope Reprocessors Market: Restraints
Lack of proper guidelines regarding proper selection and usage of automated endoscope reprocessors is expected to hamper growth of the global automated endoscope reprocessors market. Ill-advised endoscope cleaning can bring about danger of building up an extreme contamination. Claims have been recorded against manufacturers, asserting the device outlines keep legitimate sanitization from happening, putting patients at danger of genuine medical issues.
The global automated endoscope reprocessors market was valued at US$ 394.8 Mn in 2019 and is forecast to reach a value of US$ 706.3 Mn by 2027 at a CAGR of 7.4% between 2020 and 2027. Major factor driving the growth of global automated endoscope reprocessors market during the forecast period include high prevalence of diseases requiring surgical intervention, and increasing prevalence of hospital acquired infections.
Single Basin AER held dominant position in the global automated endoscope reprocessors market in 2019, accounting for 50.02% share in terms of value, followed by Dual Basin AER.
Major players in the market are focused on offering alcohol products to address customer needs during COVID-19. For instance, in June 2020, Olympus Corp. announced to offer ALPET 70/30 isopropanol alcohol rinse to address endoscope reprocessing needs due to a global shortage in the supply of alcohol, owing to the coronavirus pandemic.
Approval and launch of new devices is expected to propel growth of the global automated endoscope reprocessors market. For instance, in April 2018, The U.S. Food and Drug Administration issued 510(k) clearance for Cantel Medical to market its novel automated endoscope reprocessor The Advantage Plus Pass-Thru automated endoscope reprocessor for disinfection for commonly used endoscopes, including duodenoscopes.
Global Automated Endoscope Reprocessors Market: Competitive Landscape
Major players operating in the global automated endoscope reprocessors market include, STERIS Plc., Olympus Corporation, Laboratory Anios, Hoya Corporation, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Advanced Sterilization Products, Custom Ultrasonics, and Johnson & Johnson.
Global Automated Endoscope Reprocessors Market: Key Developments
April 2020: Cantel Medical Corporation announced its focus on enhanced production, product innovation and value-add COVID-19 education in support of first-responders and other healthcare professionals to combat the COVID-19 virus
March 2020: Olympus Corporation announced its top customer service satisfaction rating in MD Buyline, a U.S.-based healthcare analytics company’s, Low-Temp Sterilizer and High-Level Disinfector category for the 8th consecutive quarter
Joining thousands of companies around the world committed to making the Excellent Business Solutions.